二肽
流动化学
过程(计算)
组合化学
连续流动
批处理
化学
催化作用
过程开发
工艺工程
更安全的
医药制造业
间歇式反应器
计算机科学
微型反应器
连续反应器
还原(数学)
反应条件
流量(数学)
开发(拓扑)
过程控制
化学合成
生化工程
作者
Michael Whittington,Longrui Chen,Jacob H. Waldman,Michael J. Di Maso,Byron K. Peters,Mark Weisel,Gerard R. Klinzing,Tuyen Cao,François Lévesque
标识
DOI:10.1021/acs.oprd.6c00369
摘要
Abstract The synthesis of enlicitide decanoate (MK-0616), a first-in-class oral PCSK9 inhibitor, requires efficient Cbz deprotection of a proline–threonine dipeptide intermediate, presenting safety and economic challenges for traditional batch hydrogenation. Here, we report the development of a continuous trickle-bed flow reactor with customized components that addresses these manufacturing constraints through systematic process optimization. This paper reports the development of a laboratory-scale trickle-bed flow reactor with customized components on a commercially available system along with catalyst characterization and continuous temperature mapping. The optimized process achieved complete conversion with 3.8% catalyst loading (24% reduction versus batch processing) and maintained a robust performance over extended operations. This comprehensive development establishes a scalable, safer alternative to batch hydrogenation while reducing precious-metal usage, providing a template for pharmaceutical flow chemistry applications requiring heterogeneous catalysis.
科研通智能强力驱动
Strongly Powered by AbleSci AI